Chlamydia antigens and corresponding DNA fragments and uses thereof
AssigneeAventis Pasteur Limited
InventorsAndrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
Life of this patent
Estimating the term…
Loading patent…
AssigneeAventis Pasteur Limited
InventorsAndrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
Estimating the term…
The present invention provides a method of immunizing a host against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The method involves nucleic acid immunization, including DNA immunization, and employs a vector containing a nucleotide sequence which encodes an ATP/ADP translocase of a strain of Chlamydia pneumoniae. The nucleotide sequence is operably linked to a promoter to effect expression of the ATP/ADP translocase in the host. The host may be a human host. Modifications are possible within the scope of this invention.
An isolated polypeptide comprising the amino acid sequence set forth as SEQ. ID.NO:2.
A vaccine comprising an isolated polypeptide comprising the amino acid sequence SEQ. ID.NO:2.
A vaccine comprising at least one fusion protein, wherein the fusion protein comprises the amino acid sequence of set forth as SEQ. ID NO:
Dependencies are inferred from the claim text.